Arena Pharmaceuticals Inc. (ARNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arena Pharmaceuticals Inc...

    NASDAQ: ARNA · Real-Time Price · USD
    99.99
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Arena Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 54K n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 54K n/a n/a n/a
    Operating Income
    		 -154.6M -194.49M -144.39M -131.99M
    Interest Income
    		 205K 205K 328K n/a
    Pretax Income
    		 -155.61M -196.31M -146.06M -118.42M
    Net Income
    		 -156.61M -196.31M -146.09M -118.42M
    Selling & General & Admin
    		 34.5M 30.3M 31.9M 29.5M
    Research & Development
    		 110.34M 94.18M 112.45M 102.53M
    Other Expenses
    		 8.64M n/a n/a n/a
    Operating Expenses
    		 153.48M 124.48M 144.35M 132.03M
    Interest Expense
    		 1M 1.03M 1.05M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 153.48M 124.48M 144.35M 132.03M
    Income Tax Expense
    		 1M -791K -615K n/a
    Shares Outstanding (Basic)
    		 61.38M 61.14M 60.79M 59.78M
    Shares Outstanding (Diluted)
    		 61.38M 61.14M 60.79M 59.78M
    EPS (Basic)
    		 -2.55 -3.21 -2.4 -1.98
    EPS (Diluted)
    		 -2.55 -3.21 -2.4 -1.98
    EBITDA
    		 -153.65M -194.31M -144.07M -117.44M
    EBIT
    		 -154.61M -195.28M -145.01M n/a
    Depreciation & Amortization
    		 954K 971K 973K 974K

    Add to Watchlist